Health Canada approves BeiGene's Brukinsa for marginal zone lymphoma
Health Canada has granted marketing approval to BeiGene’s Brukinsa to treat marginal zone lymphoma (R/R MZL) in adult individuals.
Stay updated with breaking news from Pharmaceutical Development Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Health Canada has granted marketing approval to BeiGene’s Brukinsa to treat marginal zone lymphoma (R/R MZL) in adult individuals.
Moderna and Adium Pharma have entered a distribution service agreement to commercialise the former’s Covid-19 vaccine in Latin America.
A strain of Covid-19 that combines Delta and Omicron was found in Cyprus, according to Leondios Kostrikis, at the University of Cyprus.
/PRNewswire/ -- Mikart, LLC a comprehensive contract development and manufacturing organization recently acquired a state-of-the-art Korsch XM12 to meet their...
Lykan Bioscience Welcomes Keith McCormick as Chief Financial Officer News provided by Share this article Share this article HOPKINTON, Mass., Feb. 15, 2021 /PRNewswire/ -- Lykan Bioscience, a contract Manufacturing Services Organization™ (MSO) and provider of the first true end-to-end solution for the manufacture of cell-based therapies, welcomes Keith McCormick as Chief Financial Officer. Keith brings more than 30 years of finance experience with leadership positions in several leading companies across a range of industries, geographies, and financial disciplines. As CFO, Keith is respo...